Mangoceuticals, Inc. (MGRX) Stock Statistics & Valuation Metrics

Mangoceuticals, Inc. has a market cap or net worth of $6.42M. The enterprise value is $3.48M.

Mangoceuticals, Inc. has 17,167,421 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mangoceuticals, Inc.’s return on equity (ROE) is -1.36 and return on invested capital (ROIC) is -123.53%.

The current PE Ratio of Mangoceuticals, Inc. is ―. Mangoceuticals, Inc.’s PEG ratio is 0.00676.

In the last 12 months, Mangoceuticals, Inc. had revenue of 456.02K and earned -20.64M in profits. Earnings per share was -2.05.

In the last 12 months, operating cash flow was -4.89M and capital expenditures 0.00, giving a free cash flow of -4.89M billion.

Mangoceuticals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Mangoceuticals, Inc. upcoming earnings date is ―, ―.

Mangoceuticals, Inc. as a current ratio of 1.74, with Debt / Equity ratio of 2.18%

In the past 12 months, Mangoceuticals, Inc. has paid 0.00 in taxes.

Mangoceuticals, Inc. EV to EBITDA ratio is -0.33, with an EV/FCF ratio of -1.07.

Mangoceuticals, Inc. has $174.56K in cash and marketable securities with $294.02K in debt, giving a net cash position of -$119.46K billion.

Gross margin is 52.42%, with operating margin of -4200.46%, and net profit margin of -4526.86%.

The average price target for Mangoceuticals, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―